World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
84
Citations
38853
World Ranking
862
National Ranking
454

Igor B. Roninson publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Igor B. Roninson sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 219 publications — 64th percentile

64% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Igor B. Roninson D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Igor B. Roninson sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 84 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Igor B. Roninson is affiliated with the University of South Carolina in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with notable focus on several subfields including Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Genetics, and Immunology.

Their work covers a range of main topics, notably in:

  • Advanced Breast Cancer Therapies
  • Ubiquitin and proteasome pathways
  • Epigenetics and DNA Methylation
  • Prostate Cancer Treatment and Research
  • CRISPR and Genetic Engineering
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research

Igor B. Roninson has contributed extensively to the scientific literature, with frequent publications in venues such as Cancer Research, bioRxiv (Cold Spring Harbor Laboratory), Proceedings of the National Academy of Sciences, eLife, and Atherosclerosis.

Frequent co-authors collaborating with Roninson include:

  • Mengqian Chen
  • Eugenia V. Broude
  • Jing Li
  • Victor V. Tatarskiy
  • Xiaokai Ding

Notable recent publications authored or co-authored by Igor B. Roninson include:

  • CDK8 and CDK19: positive regulators of signal-induced transcription and negative regulators of Mediator complex proteins, 2023, Nucleic Acids Research
  • Inhibition of CDK8/19 Mediator kinase potentiates HER2-targeting drugs and bypasses resistance to these agents in vitro and in vivo, 2022, Proceedings of the National Academy of Sciences
  • The Inhibition of CDK8/19 Mediator Kinases Prevents the Development of Resistance to EGFR-Targeting Drugs, 2021, Cells
  • A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched Pharmacokinetics, 2022, Journal of Medicinal Chemistry
  • Clinical Correlations of Polycomb Repressive Complex 2 in Different Tumor Types, 2021, Cancers

Best Publications

  • Guidelines for the use and interpretation of assays for monitoring autophagy

    Daniel J. Klionsky;Fabio C. Abdalla;Hagai Abeliovich;Robert T. Abraham

  • Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells

    Chang jie Chen;Janice E. Chin;Kazumitsu Ueda;Douglas P. Clark

  • Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells

    Preet M. Chaudhary;Igor B. Roninson

  • Growth retardation and increased apoptosis in mice with homozygous disruption of the akt1 gene

    William S. Chen;Pei Zhang Xu;Kathrin Gottlob;Mei Ling Chen

  • Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction.

    K. E. Noonan;C. Beck;T. A. Holzmayer;J. E. Chin

  • If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.

    Igor B. Roninson;Eugenia V. Broude;Bey-Dih Chang

  • Isolation of human mdr DNA sequences amplified in multidrug-resistant KB carcinoma cells.

    Igor B. Roninson;Janice E. Chin;Kyunghee Choi;Philippe Gros

  • Tumor Cell Senescence in Cancer Treatment

    Igor B Roninson

  • Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification.

    D.-W. Shen;A. Fojo;J. E. Chin;I. B. Roninson

  • A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents

    Bey-Dih Chang;Eugenia V. Broude;Milos Dokmanovic;Hongming Zhu

  • Hallmarks of senescence in carcinogenesis and cancer therapy.

    Jerry W Shay;Igor B Roninson

  • Effects of p21Waf1/Cip1/Sdi1 on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases.

    Bey Dih Chang;Keiko Watanabe;Eugenia V. Broude;Jing Fang

  • The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein

    Kazumitsu Ueda;Marilyn M. Cornwell;Michael M. Gottesman;Ira Pastan

  • Oncogenic functions of tumour suppressor p21Waf1/Cip1/Sdi1: association with cell senescence and tumour-promoting activities of stromal fibroblasts

    Igor B Roninson

  • An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.

    Kyunghee Choi;Chang jie Chen;Michael Kriegler;Igor B. Roninson

  • The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.

    K. Ueda;D. P. Clark;Chang-Jie Chen;I. B. Roninson

  • Methods to Detect P-Glycoprotein-associated Multidrug Resistance in Patients' Tumors: Consensus Recommendations

    William T. Beck;Thomas M. Grogan;Cheryl L. Willman;Carlos Cordon-Cardo

  • Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes [see comments]

    PM Chaudhary;EB Mechetner;IB Roninson

  • Induction of Multidrug Resistance in Human Cells by Transient Exposure to Different Chemotherapeutic Drugs

    Preet M. Chaudhary;Igor B. Roninson

  • Efficient inhibition of P-glycoprotein-mediated multidrug resistance with a monoclonal antibody

    Eugene B. Mechetner;Igor B. Roninson

Frequent Co-Authors

Andrei V. Gudkov
Andrei V. Gudkov Roswell Park Cancer Institute
Ira Pastan
Ira Pastan Center for Cancer Research
Michael M. Gottesman
Michael M. Gottesman National Institutes of Health
Wilfred D. Stein
Wilfred D. Stein Hebrew University of Jerusalem
Dale E. Bredesen
Dale E. Bredesen University of California, Los Angeles
Kazumitsu Ueda
Kazumitsu Ueda Kyoto University
Vassilis G. Gorgoulis
Vassilis G. Gorgoulis National and Kapodistrian University of Athens
Stefano Salvioli
Stefano Salvioli University of Bologna
Konstantin Chumakov
Konstantin Chumakov US Food and Drug Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology in the USA opens the door to several flexible online degree options and diverse career paths, especially in nursing and health sciences. Many students with a background in biology seek accelerated nursing credentials, such as the fastest rn to bsn program online. These programs allow students to earn qualifications quickly and begin a rewarding healthcare career.

For those aiming to build advanced expertise or transition into nursing from another field, direct entry msn programs offer pathways to a Master of Science in Nursing, even for non-nurses. Ambitious professionals may also consider rn to np programs online as a way to become nurse practitioners through efficient bridge curricula.

When researching program options, accreditation is crucial for future licensure and employment. Compare the standards at various institutions, such as Capella University, by reviewing issues like capella university nursing accreditation.

Whether you’re advancing a biology career or transitioning into healthcare, understanding these pathways will help you make informed educational choices.

Best Scientists Citing Igor B. Roninson

Trending Scientists

Recently Published Articles